ZKY001 / Zhaoke Ophthalmology 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ZKY001 / Zhaoke Ophthalmology
NCT04228926: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects

Recruiting
2
105
RoW
ZKY001 eye drops 0.3g:0.006mg, shengfatai-eye drops, the Germinal Peptide eye drops, ZKY001 eye drops 0.3g:0.012mg, ZKY001 simulated eye drops, the placebo
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Corneal Defect
12/21
12/21
NCT06213727: ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

Completed
2
180
RoW
lowe-dose ZKY001 eye drops, Medium-dose ZKY001 eye drops, ZKY001 simulated eye drops
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Corneal Epithelial Defect
11/22
11/22
TPRK, NCT06209203: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

Completed
2
120
RoW
lowe-dose ZKY001 eye drops, ZKY001, Medium-dose ZKY001 eye drops, placebo, Simulated eye drops
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Corneal Epithelium Defect
11/22
11/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ZKY001 / Zhaoke Ophthalmology
NCT04228926: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects

Recruiting
2
105
RoW
ZKY001 eye drops 0.3g:0.006mg, shengfatai-eye drops, the Germinal Peptide eye drops, ZKY001 eye drops 0.3g:0.012mg, ZKY001 simulated eye drops, the placebo
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Corneal Defect
12/21
12/21
NCT06213727: ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

Completed
2
180
RoW
lowe-dose ZKY001 eye drops, Medium-dose ZKY001 eye drops, ZKY001 simulated eye drops
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Corneal Epithelial Defect
11/22
11/22
TPRK, NCT06209203: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

Completed
2
120
RoW
lowe-dose ZKY001 eye drops, ZKY001, Medium-dose ZKY001 eye drops, placebo, Simulated eye drops
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Corneal Epithelium Defect
11/22
11/22

Download Options